Mustafa Khasraw
MBChB, MD, FRCP(Lon.), FRACP
Dr. Mustafa Khasraw is a medical oncologist at Duke University, NC, USA. He is the Deputy Director of the new Duke Center for Cancer Immunotherapy, tasked to speed up clinical research and translation for scientists across all departments at Duke who have made discoveries that show promise for developing new immunotherapies.
Prior to joining Duke in September 2019, Dr. Khasraw worked as a medical oncologist in Sydney, Australia where he was also a Clinical Lead at the Australian National Health and Medical Research Council Clinical Trial Centre at The University of Sydney where he has an ongoing honorary professorship in oncology.
Dr. Khasraw has a leading role in several clinical and translational programs and leads clinical trials with significant laboratory collaborations. He is interested in innovative trial design, targeted and immunotherapies to improve outcome of cancer patients. He is lead principal investigator on phase I, II and III multi-centre clinical trials for a number of pharmaceutical and academic groups, including the Australasian Gastrointestinal Trials Group (AGITG).
